Total Payments
$3,168
2024 Payments
$824.34
Companies
20
Transactions
83
Medicare Patients
5,155
Medicare Billing
$567,925
Payment Breakdown by Category
Food & Beverage$3,052 (96.3%)
Other$116.34 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,052 | 82 | 96.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $116.34 | 1 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $454.98 | 6 | $0 (2023) |
| STRATA Skin Sciences, Inc. | $296.65 | 2 | $0 (2024) |
| ABBVIE INC. | $251.07 | 7 | $0 (2024) |
| PFIZER INC. | $232.13 | 7 | $0 (2024) |
| Amgen Inc. | $227.16 | 8 | $0 (2021) |
| Celgene Corporation | $207.40 | 12 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $183.53 | 4 | $0 (2023) |
| Biofrontera Inc. | $177.09 | 1 | $0 (2024) |
| Allergan, Inc. | $174.39 | 6 | $0 (2022) |
| Janssen Biotech, Inc. | $125.91 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $824.34 | 11 | STRATA Skin Sciences, Inc. ($296.65) |
| 2023 | $458.85 | 11 | Merz North America, Inc. ($150.00) |
| 2022 | $195.40 | 9 | Incyte Corporation ($88.49) |
| 2021 | $95.86 | 4 | Amgen Inc. ($81.39) |
| 2020 | $153.92 | 7 | Amgen Inc. ($90.63) |
| 2019 | $414.46 | 11 | Allergan Inc. ($140.34) |
| 2018 | $216.21 | 3 | Merz North America, Inc. ($141.18) |
| 2017 | $808.82 | 27 | Celgene Corporation ($178.18) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $116.63 | General |
| Category: Dermatology | ||||||
| 10/26/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Inflammation & Immunology | ||||||
| 09/27/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $93.53 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $177.09 | General |
| Category: DERMATOLOGY | ||||||
| 08/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $30.65 | General |
| 07/31/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $28.07 | General |
| 07/17/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $180.02 | General |
| Category: Dermatology | ||||||
| 07/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: DERMATOLOGY | ||||||
| 03/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: FACIAL AESTHETICS | ||||||
| 01/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $97.69 | General |
| Category: Immunology | ||||||
| 10/18/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Musculoskeletal | ||||||
| 09/12/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: DERMATOLOGY | ||||||
| 08/16/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: DERMATOLOGY | ||||||
| 07/27/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: DERMATOLOGY | ||||||
| 06/06/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: DERMATOLOGY | ||||||
| 04/25/2023 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $26.11 | General |
| 04/05/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/28/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Dermatology | ||||||
| 03/14/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: DERMATOLOGY | ||||||
| 08/22/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.22 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,716 | 2,991 | $617,311 | $152,396 |
| 2022 | 14 | 970 | 2,495 | $506,648 | $130,428 |
| 2021 | 13 | 1,282 | 3,211 | $611,496 | $162,350 |
| 2020 | 14 | 1,187 | 2,744 | $504,110 | $122,752 |
Total Patients
5,155
Total Services
11,441
Medicare Billing
$567,925
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 508 | 758 | $174,711 | $52,216 | 29.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 215 | 267 | $96,259 | $22,517 | 23.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 191 | $65,295 | $18,347 | 28.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 160 | 160 | $55,022 | $12,327 | 22.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 138 | 165 | $55,440 | $12,068 | 21.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 65 | 75 | $42,984 | $10,053 | 23.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 195 | 242 | $64,060 | $9,977 | 15.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 158 | 962 | $22,857 | $5,537 | 24.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 51 | 77 | $13,706 | $3,385 | 24.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 18 | 21 | $9,023 | $2,130 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $7,940 | $1,392 | 17.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 12 | 13 | $4,714 | $1,268 | 26.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $5,076 | $1,152 | 22.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 33 | $222.75 | $27.92 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 247 | 460 | $157,256 | $42,186 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 218 | 414 | $95,423 | $26,976 | 28.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 106 | 153 | $55,160 | $13,166 | 23.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 111 | 248 | $65,648 | $11,560 | 17.6% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 12 | 29 | $15,950 | $8,630 | 54.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 25 | 44 | $25,217 | $5,321 | 21.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 88 | 931 | $22,121 | $5,256 | 23.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 60 | 74 | $24,864 | $5,138 | 20.7% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2022 | 12 | 25 | $9,666 | $4,510 | 46.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 19 | 28 | $12,031 | $2,852 | 23.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $12,380 | $2,484 | 20.1% |
About Dr. Alex Carcamo, M.D
Dr. Alex Carcamo, M.D is a Procedural Dermatology healthcare provider based in Mililani, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992759211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alex Carcamo, M.D has received a total of $3,168 in payments from pharmaceutical and medical device companies, with $824.34 received in 2024. These payments were reported across 83 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($3,052).
As a Medicare-enrolled provider, Carcamo has provided services to 5,155 Medicare beneficiaries, totaling 11,441 services with total Medicare billing of $567,925. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Procedural Dermatology
- Location Mililani, HI
- Active Since 05/20/2006
- Last Updated 05/24/2016
- Taxonomy Code 207NS0135X
- Entity Type Individual
- NPI Number 1992759211
Products in Payments
- XTRAC (Device) $296.65
- Otezla (Drug) $215.63
- AMELUZ (Drug) $177.09
- Xeomin (Biological) $150.00
- COSENTYX (Biological) $138.84
- Enbrel (Biological) $136.53
- CIBINQO (Drug) $135.00
- Humira (Biological) $127.81
- BOTOX COSMETIC (Biological) $124.54
- REMICADE (Biological) $111.98
- ADBRY (Biological) $110.69
- Sotyktu (Drug) $97.69
- EUCRISA (Drug) $97.13
- Santyl (Drug) $94.01
- ILUMYA (Biological) $93.53
- OPZELURA (Drug) $88.49
- EPIDUO FORTE (Drug) $54.07
- BOTOX (Biological) $42.87
- ASTRA TECH Implant System (Device) $42.70
- Finacea (Drug) $41.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.